Clarus Lifesciences III, L.P. is 10% at Gritstone Oncology, Inc. (GRTS). They have made 1 open-market trade across 1 company since 2018, most recently 2021-05-12.
CIK 0001597143
1 open-market purchase totalling $5.0M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTS | BUY | 2018-09-28 | 2018-10-02 | $15.00 | $5.0M | -1.3% | +51.0% | +22.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.